后抗生素时代尿路感染的抗生素管理:聚焦诊断与抗菌药物管理的叙述性综述
该叙述性综述通过定向PubMed检索与手工检索参考文献,回顾成人女性尿路感染的诊断与治疗关键临床决策,重点关注临床有效性及诊断与抗菌药物管理;未设定严格时间限制,优先纳入近期发表、随机试验和系统综述,检索限于英文文献,未进行正式质量评估。
要点
- 常见尿路病原体耐药性持续上升,对尿路感染管理产生实质影响。
- 诊断需综合定义与分类、床旁评估与即时检验、实验室检查指征。
- 治疗决策需兼顾患者临床有效性与不良反应及群体层面抗菌药物选择压力。
核心结论
- 常见尿路病原体耐药性稳步上升,对尿路感染管理产生实质影响。
- 诊断与治疗中,临床医生需同时考虑患者的临床有效性与不良反应(包括附带损害)及更广泛群体的种群层面抗菌药物选择压力。
研究设计与样本
- 叙述性综述,通过定向PubMed检索及手工检索纳入研究的参考文献列表来识别关键文献。
- 未设定严格时间限制,优先纳入近期发表、随机试验和系统综述(含或不含Meta分析)。
- 检索限于英文文献,未进行正式质量评估,但作者在撰写过程中审阅了每篇论文的优势与局限性。
主要发现
- 综述讨论了门诊成人女性尿路感染的管理,尤其关注非复杂性感染。
- 诊断方面涵盖定义与分类、床旁评估与即时检验、实验室检查的指征与使用。
- 治疗方面涵盖治疗指征、抗菌药物节约策略、选择特定抗菌药物时的关键考虑、特定治疗场景及治疗疗程。
- 最后概述了该领域新兴关注方向。
局限性
- 未设定严格的时间限制。
- 检索限于英文语言文章。
- 未进行正式的质量评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As one of the most common indications for antimicrobial prescription in the community, the management of urinary tract infections (UTIs) is both complicated by, and a driver of, antimicrobial resistance. OBJECTIVES: To highlight the key clinical decisions involved in the diagnosis and treatment of UTIs in adult women, focusing on clinical effectiveness and both diagnostic and antimicrobial stewardship as we approach the post-antimicrobial era. SOURCES: Literature reviewed via directed PubMed searches and manual searching of the reference list for included studies to identify key references to respond to the objectives. A strict time limit was not applied. We prioritised recent publications, randomised trials, and systematic reviews (with or without meta-analyses) where available. Searches were limited to English language articles. A formal quality assessment was not performed; however, the strengths and limitations of each paper were reviewed by the authors throughout the preparation of this manuscript. CONTENT: We discuss the management of UTIs in ambulatory adult women, with particular focus on uncomplicated infections. We address the diagnosis of UTIs, including the following: definition and categorisation; bedside assessments and point-of-care tests; and the indications for, and use of, laboratory tests. We then discuss the treatment of UTIs, including the following: indications for treatment, antimicrobial sparing approaches, key considerations when selecting a specific antimicrobial agent, specific treatment scenarios, and duration of treatment. We finally outline emerging areas of interest in this field. IMPLICATIONS: The steady increase in antimicrobial resistance among common uropathogens has had a substantial affect on the management of UTIs. Regarding both diagnosis and treatment, the clinician must consider both the patient (clinical effectiveness and adverse effects, including collateral damage) and the community more broadly (population-level antimicrobial selection pressure).
引用
- Abbott IJ, Peel TN, Cairns KA, et al. Antibiotic management of urinary tract infections in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship. Clin Microbiol Infect. 2022. PMID: 35640839. doi:10.1016/j.cmi.2022.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。